Acadian Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.12M Sell
226,935
-390,137
-63% -$16.5M 0.01% 695
2026
Q1
$34.1M Sell
617,072
-85,576
-12% -$4.07M 0.05% 292
2025
Q4
$26.2M Sell
702,648
-83,172
-11% -$3.38M 0.04% 296
2025
Q3
$31.8M Buy
785,820
+61,378
+8% +$2.03M 0.06% 253
2025
Q2
$18.5M Sell
724,442
-58,497
-7% -$1.28M 0.04% 331
2025
Q1
$16.7M Buy
782,939
+4,144
+0.5% +$92.6K 0.05% 250
2024
Q4
$16.3M Buy
778,795
+60,478
+8% +$1.4M 0.05% 265
2024
Q3
$16.2M Buy
718,317
+811
+0.1% +$15.7K 0.05% 261
2024
Q2
$12M Buy
717,506
+42,299
+6% +$680K 0.04% 304
2024
Q1
$8.73M Buy
675,207
+166,776
+33% +$2M 0.03% 337
2023
Q4
$5.88M Buy
508,431
+83,459
+20% +$942K 0.02% 409
2023
Q3
$5.42M Sell
424,972
-76,886
-15% -$1.09M 0.02% 413
2023
Q2
$6.87M Sell
501,858
-78,161
-13% -$1.12M 0.03% 373
2023
Q1
$8.88M Sell
580,019
-150,964
-21% -$2.31M 0.04% 330
2022
Q4
$9.79M Buy
730,983
+233,816
+47% +$3.14M 0.05% 286
2022
Q3
$6.6M Buy
497,167
+313,819
+171% +$5.42M 0.04% 343
2022
Q2
$3.51M Sell
183,348
-24,278
-12% -$460K 0.02% 498
2022
Q1
$4.13M Buy
207,626
+63,373
+44% +$1.28M 0.02% 504
2021
Q4
$2.94M Sell
144,253
-44,613
-24% -$953K 0.01% 570
2021
Q3
$4.05M Sell
188,866
-67,381
-26% -$1.62M 0.02% 506
2021
Q2
$7.4M Sell
256,247
-68,256
-21% -$1.85M 0.03% 377
2021
Q1
$7.92M Sell
324,503
-16,045
-5% -$362K 0.03% 370
2020
Q4
$6.61M Buy
340,548
+44,352
+15% +$816K 0.03% 431
2020
Q3
$5.16M Sell
296,196
-601
-0.2% -$12.8K 0.02% 433
2020
Q2
$7.8M Sell
296,797
-1,482
-0.5% -$36.8K 0.03% 379
2020
Q1
$7.21M Buy
298,279
+18,575
+7% +$454K 0.04% 316
2019
Q4
$6.95M Sell
279,704
-28,223
-9% -$655K 0.03% 375
2019
Q3
$6.57M Buy
307,927
+29,164
+10% +$799K 0.03% 413
2019
Q2
$8.86M Sell
278,763
-16,952
-6% -$532K 0.04% 297
2019
Q1
$9.76M Sell
295,715
-29,170
-9% -$908K 0.04% 310
2018
Q4
$10.4M Sell
324,885
-7,612
-2% -$287K 0.05% 255
2018
Q3
$14.3M Buy
332,497
+101,683
+44% +$4.8M 0.06% 246
2018
Q2
$10.6M Buy
230,814
+16,090
+7% +$712K 0.05% 292
2018
Q1
$8.52M Buy
214,724
+31,801
+17% +$1.18M 0.04% 334
2017
Q4
$6.13M Buy
182,923
+18,514
+11% +$657K 0.03% 343
2017
Q3
$6.09M Buy
164,409
+35,349
+27% +$1.33M 0.03% 341
2017
Q2
$4.78M Buy
129,060
+82,524
+177% +$2.69M 0.02% 406
2017
Q1
$1.31M Buy
+46,536
New +$1.31M 0.01% 714
2016
Q2
Sell
-74,153
Closed -$2M 1495
2016
Q1
$2M Buy
74,153
+5,616
+8% +$161K 0.01% 550
2015
Q4
$2.06M Buy
68,537
+59,388
+649% +$1.91M 0.01% 565
2015
Q3
$289K Buy
+9,149
New +$334K ﹤0.01% 850
2015
Q2
Sell
-58,158
Closed -$2.06M 1463
2015
Q1
$2.06M Sell
58,158
-4,218
-7% -$136K 0.01% 538
2014
Q4
$1.97M Buy
62,376
+57,527
+1,186% +$1.59M 0.01% 527
2014
Q3
$109K Buy
+4,849
New +$97.1K ﹤0.01% 824

Other funds holding PAHC

Acadian Asset Management's PAHC Position: Q2 2026 in Review

Acadian Asset Management reduced its Phibro Animal Health (PAHC) stake by 63% in Q2 2026, selling an estimated $16.5M and leaving 226,935 shares worth $7.12M. The position accounts for 0.01% of the portfolio, ranked #695.

Acadian Asset Management first reported a position in PAHC in Q3 2014 and has held it in 44 quarters since. The position peaked at $34.1M in Q1 2026. 153 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Acadian Asset Management held 226,935 shares of Phibro Animal Health worth $7.12M as of Q2 2026.
  • Acadian Asset Management sold 390,137 Phibro Animal Health shares in Q2 2026, an estimated $16.5M.
  • Phibro Animal Health made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #695 holding.
  • Acadian Asset Management first reported a position in Phibro Animal Health in Q3 2014 and has held it in 44 quarters since.
  • Acadian Asset Management's Phibro Animal Health position peaked at $34.1M in Q1 2026.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.